Abacavir, Dolutegravir, Lamivudine

Abacavir, Dolutegravir, and Lamivudine is a combination medication used for the treatment of HIV, a virus that attacks the immune system. This medication works by preventing the virus from replicating in the body, thereby reducing the amount of virus present and slowing the progression of the disease.
Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI) that works by interfering with the enzyme responsible for replicating the HIV virus. Dolutegravir, on the other hand, is an integrase strand transfer inhibitor (INSTI) that prevents the integration of the viral DNA into the host’s DNA, effectively stopping the virus from reproducing. Lamivudine is another NRTI that also targets the reverse transcriptase enzyme.
This combination medication is typically prescribed for patients who have not previously received treatment for HIV or those who have experienced treatment failure with other medications. It is important to follow the prescribed dosage and take the medication as directed to ensure its effectiveness.
Patients taking Abacavir, Dolutegravir, and Lamivudine should be monitored for any potential side effects, such as hypersensitivity reactions, which can be severe and life-threatening. Regular blood tests are also necessary to monitor for potential changes in liver function and other potential side effects.